Managing the Economic Challenges in the Treatment of Heart Failure
Overview
Authors
Affiliations
Background: Treatment of heart failure is complex and inherently challenging. Patients traverse multiple practice settings as inpatients and outpatients, often resulting in fragmented care. The Center for Medicare and Medicaid Services is implementing payment programs that reward delivery of high-quality, cost-effective care, and one of the newer programs, the Bundled Payment for Care Improvement Advanced program, attempts to improve the coordination of care across practices for a hospitalization episode and post-acute care. The quality and cost of care contribute to its value, but value may be defined in different ways by different entities.
Conclusions: The rapidly changing world of digital health may contribute to or detract from the quality and cost of care. Health systems, payers, and patients are all grappling with these issues, which were reviewed at a symposium at the Heart Failure Society of America conference in Philadelphia, Pennsylvania on September 14, 2019. This article constitutes the proceedings from that symposium.
Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients.
Unlu O, Bhatt A, Blood A JACC Adv. 2024; 3(7):101024.
PMID: 39129982 PMC: 11312769. DOI: 10.1016/j.jacadv.2024.101024.
Gut Permeability and Immune-Mediated Inflammation in Heart Failure.
Perticone M, Gigliotti S, Shehaj E, Maio R, Suraci E, Miceli S Biomedicines. 2024; 12(6).
PMID: 38927424 PMC: 11200601. DOI: 10.3390/biomedicines12061217.
Cheko J, Patsalis N, Kreutz J, Divchev D, Chatzis G, Schieffer B J Pers Med. 2024; 14(1).
PMID: 38248718 PMC: 10820131. DOI: 10.3390/jpm14010017.
A telemonitoring programme in patients with heart failure in France: a cost-utility analysis.
Caillon M, Sabatier R, Legallois D, Courouve L, Donio V, Boudevin F BMC Cardiovasc Disord. 2022; 22(1):441.
PMID: 36217130 PMC: 9549824. DOI: 10.1186/s12872-022-02878-1.